PPP1R12C 在心房动中促进心房低收缩性
Srikanth Perike1,2,3, Francisco J Gonzalez-Gonzalez1,2,3, Issam Abu-Taha4
1Division of Cardiology, Department of Medicine, College of Medicine (S.P., F.J.G.-G., K.S.L., A.A., A.E.C., A.S., J.G., S.-G.O., D. Darbar, B.M.W., M.D.M.), University of Illinois at Chicago.
Circulation research
|September 22, 2023
概括
在心房动 (AF) 中增加的PPP1R12C蛋白质通过去酸化MLC2a来降低心房收缩性. 这种分子机制有助于AF患者中风风险.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 心房动 (AF) 是最常见的心律失常,显著增加中风风险.
- 心房缺约性是已知的AF中风风险的贡献者,但其分子基础尚不清楚.
- 这项研究研究了PPP1R12C (蛋白质酸酶1调节子单元12C) 在AF相关的心房低收缩性中的作用.
研究的目的:
- 测试假设增加PPP1R12C表达会通过降低MLC2a (心房髓光链2) 酸化而导致心房低收缩性.
- 阐明AF中PPP1R12C,PP1 (蛋白酸酶1) 和MLC2a之间的分子机制.
主要方法:
- 来自AF患者和对照组的人类心房附属体组织的分析.
- 西方涂抹,共免疫沉和酸化研究,以评估蛋白质相互作用和修饰.
- 使用HL-1细胞和药理抑制剂的体外研究,以及与小鼠心脏特异性lentiviral PPP1R12C过度表达的体内研究.
主要成果:
- 与对照组相比,人类AF患者的PPP1R12C表达增加了2倍,MLC2a酸化减少了>40%.
- 在AF中观察到增加的PPP1R12C-PP1c和PPP1R12C-MLC2a结合.
- 患有PPP1R12C过度表达的小鼠表现出心房膨胀,心房功能减弱和显著更高的AF诱导性.
结论:
- 在AF患者中,PPP1R12C水平升高与心房收缩率降低相关.
- 在小鼠中,PPP1R12C过度表达导致MLC2a脱,心房收缩率降低,心房动脉敏感性增加.
- 通过MLC2a通过PP1调节瘤细胞功能是AF期间心房收缩的一个关键因素.
相关概念视频
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
764
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
764
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
33
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
33
Disturbances in Heart Rhythm
997
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
997
Dysrhythmias IV: Characteristics of Bradyarrhythmias
11
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
11


